| 000 | 02828 a2200805 4500 | ||
|---|---|---|---|
| 005 | 20250513223346.0 | ||
| 264 | 0 | _c20001213 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a1061-4036 | ||
| 024 | 7 |
_a10.1038/81583 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobs, J J | |
| 245 | 0 | 0 |
_aSenescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. _h[electronic resource] |
| 260 |
_bNature genetics _cNov 2000 |
||
| 300 |
_a291-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCOS Cells |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xgenetics |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCellular Senescence _xgenetics |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 17 _xgenetics |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p16 |
| 650 | 0 | 4 | _aDNA-Binding Proteins |
| 650 | 0 | 4 | _aE2F Transcription Factors |
| 650 | 0 | 4 | _aE2F1 Transcription Factor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aNeoplastic Syndromes, Hereditary _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 | _aPolycomb Repressive Complex 1 |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aProtein Biosynthesis |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRepressor Proteins _xgenetics |
| 650 | 0 | 4 | _aRetinoblastoma-Binding Protein 1 |
| 650 | 0 | 4 |
_aT-Box Domain Proteins _xgenetics |
| 650 | 0 | 4 | _aTranscription Factor DP1 |
| 650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aTumor Suppressor Protein p14ARF |
| 700 | 1 | _aKeblusek, P | |
| 700 | 1 | _aRobanus-Maandag, E | |
| 700 | 1 | _aKristel, P | |
| 700 | 1 | _aLingbeek, M | |
| 700 | 1 | _aNederlof, P M | |
| 700 | 1 | _avan Welsem, T | |
| 700 | 1 | _avan de Vijver, M J | |
| 700 | 1 | _aKoh, E Y | |
| 700 | 1 | _aDaley, G Q | |
| 700 | 1 | _avan Lohuizen, M | |
| 773 | 0 |
_tNature genetics _gvol. 26 _gno. 3 _gp. 291-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/81583 _zAvailable from publisher's website |
| 999 |
_c11004992 _d11004992 |
||